This company has shut down. Scout Bio is no longer operating — its last tracked round was a Series B in 2021.
Explore the Startup GraveyardScout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.
Scout Bio has raised $33.0M in total funding. The most recent round was Series B. The last funding was announced in October 2021.
Scout Bio's investors include Adage Capital Management, OrbiMed, Correlation Ventures, Frazier Healthcare Partners, Digitalis Ventures.
Scout Bio is headquartered in Philadelphia, United States.
Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.
Scout Bio is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scout Bio — Funding & Investors." VCBacked, October 19, 2021, https://www.vcbacked.co/company/scout-bio. Accessed August 14, 2026.
VCBacked. (2021). Scout Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/scout-bio
{{cite web |title=Scout Bio — Funding & Investors |url=https://www.vcbacked.co/company/scout-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated